Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

The mucus-bicarbonate barrier is the stomach's primary defense mechanism against gastric acid and pepsin. The mucus layer prevents direct acid contact with the stomach lining, while bicarbonate secretion neutralizes acid and maintains a protective pH. This barrier is essential for protecting the gastrointestinal lining from corrosive damage and preventing peptic ulcer disease.

Helicobacter pylori impairs somatostatin production, a hormone that regulates acid secretion. This leads to increased gastric acid production and reduced bicarbonate levels, weakening the mucosal-bicarbonate barrier. The combined effect of elevated acid and diminished defense mechanisms creates conditions favorable for ulcer development and chronic peptic ulcer disease.

Prostaglandins support gastric mucosal health by stimulating bicarbonate secretion, reducing gastric acid production, and maintaining mucosal blood flow. These cytoprotective actions strengthen the mucosal-bicarbonate barrier and protect the stomach lining from acid injury. Drugs for peptic ulcer disease prostaglandin analogs as mucosal protective agents work by mimicking these natural protective effects.

Nonsteroidal anti-inflammatory drugs inhibit prostaglandin production, which reduces gastric mucus secretion and mucosal blood flow. These changes weaken the mucosal-bicarbonate barrier and increase vulnerability to gastric acid damage. By suppressing the body's natural protective mechanisms, NSAIDs significantly elevate the risk of developing peptic ulcer disease.

Bicarbonate is a crucial component of the mucosal-bicarbonate barrier that neutralizes stomach acid and maintains a protective pH. A decline in bicarbonate production tips the balance toward an acidic environment, injuring the stomach lining and setting the stage for peptic ulcer disease. Maintaining adequate bicarbonate levels is essential for mucosal defense.

Duodenogastric reflux and atrophic gastritis are disturbances that can weaken the mucosal-bicarbonate barrier and lead to chronic peptic ulcer disease. These conditions render the stomach lining vulnerable to the erosive effects of gastric acid and pepsin. Understanding these pathophysiological factors is important for comprehensive management of peptic ulcer disease.

Peptic ulcer disease develops when aggressive factors like gastric acid and pepsin overwhelm mucosal defense mechanisms. The mucus-bicarbonate barrier, prostaglandins, and adequate mucosal blood flow normally protect the stomach lining. When infections, medications, or other disturbances impair these defenses or increase acid secretion, ulceration occurs.